Khuda Dad Khan

1.8k total citations
29 papers, 1.5k citations indexed

About

Khuda Dad Khan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Khuda Dad Khan has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Khuda Dad Khan's work include Chronic Lymphocytic Leukemia Research (6 papers), T-cell and B-cell Immunology (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Khuda Dad Khan is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), T-cell and B-cell Immunology (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Khuda Dad Khan collaborates with scholars based in United States, Australia and Germany. Khuda Dad Khan's co-authors include Stuart Maudsley, Louis M. Luttrell, Alfred L.M. Bothwell, Michael Yellin, Kristen L. Pierce, Glen Lindwall, Stephen E. Maher, Steven O’Day, Wolfram E. Samlowski and John D. Powderly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Khuda Dad Khan

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khuda Dad Khan United States 16 715 622 512 251 144 29 1.5k
Michelle Kuhne United States 14 788 1.1× 933 1.5× 1.1k 2.1× 177 0.7× 243 1.7× 35 2.2k
Yen K. Lieu United States 16 295 0.4× 674 1.1× 660 1.3× 248 1.0× 143 1.0× 21 1.9k
Mariko Takahashi-Tezuka Japan 7 850 1.2× 803 1.3× 655 1.3× 120 0.5× 114 0.8× 8 1.5k
Maria Teresa Sabrina Bertilaccio Italy 25 430 0.6× 550 0.9× 837 1.6× 339 1.4× 632 4.4× 51 1.7k
Gunhild Trøen Norway 21 271 0.4× 439 0.7× 199 0.4× 329 1.3× 226 1.6× 46 1.1k
Andreas Hüttmann Germany 21 523 0.7× 367 0.6× 304 0.6× 600 2.4× 449 3.1× 66 1.7k
Mikinori Sato Japan 19 704 1.0× 603 1.0× 214 0.4× 122 0.5× 38 0.3× 59 1.4k
Richard C. Frank United States 21 986 1.4× 1.1k 1.8× 233 0.5× 616 2.5× 236 1.6× 50 2.4k
Tanja Holopainen Finland 21 1.3k 1.9× 1.2k 1.9× 144 0.3× 103 0.4× 78 0.5× 27 2.1k
Martín A. Rivas Argentina 17 845 1.2× 761 1.2× 246 0.5× 135 0.5× 173 1.2× 27 1.6k

Countries citing papers authored by Khuda Dad Khan

Since Specialization
Citations

This map shows the geographic impact of Khuda Dad Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khuda Dad Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khuda Dad Khan more than expected).

Fields of papers citing papers by Khuda Dad Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khuda Dad Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khuda Dad Khan. The network helps show where Khuda Dad Khan may publish in the future.

Co-authorship network of co-authors of Khuda Dad Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Khuda Dad Khan. A scholar is included among the top collaborators of Khuda Dad Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khuda Dad Khan. Khuda Dad Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boccia, Ralph V., Pedro Sanz-Altamira, Khuda Dad Khan, et al.. (2017). Examining the Frequency of Phlebotomy in Patients with Polycythemia Vera (PV) in the United States: An Analysis of Data from the REVEAL Study. Blood. 130. 5271–5271. 2 indexed citations
2.
Rizzieri, David A., Samantha LoRusso, William Tse, et al.. (2010). Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia. Clinical Lymphoma Myeloma & Leukemia. 10(3). 211–216. 9 indexed citations
3.
Hersh, Evan M., Steven O’Day, John D. Powderly, et al.. (2010). A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma. Investigational New Drugs. 29(3). 489–498. 237 indexed citations
4.
Ansell, Stephen M., Steven M. Horwitz, Andreas Engert, et al.. (2008). Increased doses of an anti-CD30 antibody, MDX-060, results in prolonged progression free survival in subjects with CD30 positive lymphoma.. Cancer Research. 68. 5525–5525. 2 indexed citations
5.
Talaulikar, Dipti, Bruce Shadbolt, JOHN R. BELL, et al.. (2008). Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B‐cell lymphoma (DLBCL) – a new perspective. Histopathology. 52(3). 340–347. 12 indexed citations
6.
Ansell, Stephen M., Steven M. Horwitz, Andreas Engert, et al.. (2007). Phase I/II Study of an Anti-CD30 Monoclonal Antibody (MDX-060) in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma. Journal of Clinical Oncology. 25(19). 2764–2769. 193 indexed citations
7.
Khan, Khuda Dad, Susan O’Brien, Michael R. Kanost, et al.. (2006). Phase II study of talabostat and rituximab in fludarabine/rituximab-resistant or refractory patients with CLL. Journal of Clinical Oncology. 24(18_suppl). 6598–6598. 4 indexed citations
8.
Halbert, Ronald J., Robert A. Figlin, Michael B. Atkins, et al.. (2006). Treatment of patients with metastatic renal cell cancer. Cancer. 107(10). 2375–2383. 50 indexed citations
9.
Rizzieri, David A., William Ka Fai Tse, Khuda Dad Khan, et al.. (2006). A Phase I Study of Cloretazine® and Temozolomide in Patients with Hematologic Malignancies.. Blood. 108(11). 1971–1971. 1 indexed citations
10.
Khan, Khuda Dad, Susan O’Brien, R. Kanti, et al.. (2005). Phase 2 Study of Talabostat and Rituximab in Patients with Advanced Chronic Lymphoctyic Leukemia (CLL) Previously Treated with a Rituximab/Fludarabine Regimen.. Blood. 106(11). 2125–2125. 1 indexed citations
11.
Powderly, John D., Khuda Dad Khan, Jon Richards, et al.. (2005). A 2-stage controlled phase 1/2 study of STA-4783 in combination with paclitaxel in patients with advanced metastatic melanoma. Journal of Clinical Oncology. 23(16_suppl). 7561–7561. 4 indexed citations
12.
Giles, Frank, Stephen J. O’Brien, Norbert Vey, et al.. (2005). Phase II study of VNP40101M in patients (pts) with acute myelogenous leukemia (AML) and high-risk myelodysplasia (MDS). Journal of Clinical Oncology. 23(16_suppl). 6541–6541. 3 indexed citations
13.
Ansell, Stephen M., John C. Byrd, Steven M. Horwitz, et al.. (2004). Phase I/II, Open-Label, Dose-Escalating Study of MDX-060 Administered Weekly for 4 Weeks in Subjects with Refractory/Relapsed CD30 Positive Lymphoma.. Blood. 104(11). 2636–2636. 17 indexed citations
14.
Giles, Francis J., Maureen Cooper, Lewis R. Silverman, et al.. (2003). Phase II study of SU5416—a small‐molecule, vascular endothelial growth factor tyrosine‐kinase receptor inhibitor—in patients with refractory myeloproliferative diseases. Cancer. 97(8). 1920–1928. 65 indexed citations
15.
Pierce, Kristen L., et al.. (2000). Transactivation of the EGF Receptor Mediates IGF-1-stimulated Shc Phosphorylation and ERK1/2 Activation in COS-7 Cells. Journal of Biological Chemistry. 275(29). 22583–22589. 229 indexed citations
16.
Miller, William E., Stuart Maudsley, Seungkirl Ahn, et al.. (2000). β-Arrestin1 Interacts with the Catalytic Domain of the Tyrosine Kinase c-SRC. Journal of Biological Chemistry. 275(15). 11312–11319. 166 indexed citations
17.
Khan, Khuda Dad, et al.. (1999). Complex Regulation of Ly-6E Gene Transcription in T Cells by IFNs. The Journal of Immunology. 163(2). 811–819. 19 indexed citations
18.
Caplin, M., Kay Savage, Khuda Dad Khan, et al.. (1998). Expression and processing of gastrin in patients with hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma. Gastroenterology. 114. A1219–A1219. 1 indexed citations
19.
Khan, Khuda Dad, Ke Shuai, Glen Lindwall, et al.. (1993). Induction of the Ly-6A/E gene by interferon alpha/beta and gamma requires a DNA element to which a tyrosine-phosphorylated 91-kDa protein binds.. Proceedings of the National Academy of Sciences. 90(14). 6806–6810. 145 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle Kuhne Breakdown of academic impact, for papers by Yen K. Lieu Breakdown of academic impact, for papers by Mariko Takahashi-Tezuka Breakdown of academic impact, for papers by Maria Teresa Sabrina Bertilaccio Breakdown of academic impact, for papers by Gunhild Trøen Breakdown of academic impact, for papers by Andreas Hüttmann Breakdown of academic impact, for papers by Mikinori Sato Breakdown of academic impact, for papers by Richard C. Frank Breakdown of academic impact, for papers by Tanja Holopainen Breakdown of academic impact, for papers by Martín A. Rivas
Rankless by CCL
2026